Nasdaq: CORT
Corcept Therapeutics insiders
The officers, directors and 10% owners of Corcept Therapeutics Incorporated who hold the most stock, valued at the live CORT price.
$64.98
CORT today −$2.8M (−4.15%)
Market closed. Prices as of Nov 19, 4:04 PM ET
- Ranked insiders
- 5
- Their CORT stock
- $910M
- Market value
- $7.11B
- Held by ranked insiders
- 12.8%
Insiders by value of CORT holdings
SEC ownership page| # | Insider | Role | Shares | Value | Of company | Overall rank |
|---|---|---|---|---|---|---|
| 1 | Joseph K. Belanoff | Chief Executive Officer | 5,660,013 | $368M | 5.17% | 580th |
| 2 | James N. Wilson | Director | 3,483,618 | $226M | 3.18% | 818th |
| 3 | David L Mahoney | Director | 2,370,684 | $154M | 2.17% | 1077th |
| 4 | G. Leonard Baker Jr. | Director | 2,241,893 | $146M | 2.05% | 1126th |
| 5 | Hazel Hunt | Chief Scientific Officer | 255,437 | $16.6M | 0.23% | 5954th |
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Corcept Therapeutics; see each profile for the filing.